CME Information: 1.0 AMA PRA Category 1 Credits^TM

Release Date: October, 2020

Expiration Date (Enduring Version): October, 2023

PLEASE NOTE: Users who attended the live version of this webinar cannot also claim CME credit for the On-Demand Version. CME credit can only be claimed one time. 

Introduction

This webinar will focus on the role of imaging in cardiac amyloidosis. Tips and tricks on optimal imaging strategies for the sonographer audience will be provided. A comprehensive review of the role of echocardiography from basic to advanced techniques, including an evaluation of the role of strain imaging, will be discussed. Finally, attendees will learn about the optimal use of multimodality imaging as part of the diagnostic algorithm in the evaluation of cardiac amyloidosis. This will be a live interactive session with time allotted for questions and answers.

Moderator(s): Allan Klein, MD, FASE; Dermont Phelan, MD, PhD, FASE

Speaker(s): Sarah Cuddy, MB, BCh; Madeline Jankowski, BS, RDCS, FASE; Jai Singh, MD

Target Audience: This activity is designed for all cardiovascular sonographers and physicians with a primary interest and knowledge base in the field of cardiovascular imaging including echocardiography, cardiac magnetic resonance imaging, nuclear imaging, and others. In addition, it is designed for cardio-oncologists, oncologists, residents, researchers, clinicians, intensivists, and other medical professionals.

Learning Objectives:

1. Understand the challenges of identifying patients with cardiac amyloidosis and have strategies for differentiating cardiac amyloidosis from other causes of increased ventricular wall thickness.
2. Summarize the diagnostic evaluation for cardiac amyloidosis, including the differential diagnosis using echocardiography.
3. Demonstrate an understanding of the role of multi-modality imaging in the evaluation of cardiac amyloidosis. 

• Contact:
  Tech Support
• Training Hours: 1.00